Daily pill doubles survival time for pancreatic cancer patients

Daily pill doubles survival time for pancreatic cancer patients1 hour agoShareSaveAdd as preferred on GoogleChris GrahamReutersA pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer.The drug, called daraxonrasib, appears to be a breakthrough in managing a disease that has the highest mortality rate of all major cancers.It helps prevent the spread of cancer by locking onto and shutting off the mutated K... Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancerA daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of a clinical trial that experts are saying is a “gamechanger” and one of the biggest breakthroughs in decades.Currently, there are few treatments for pancreatic cancer, and most do little or nothing to help.